An application of ERBB2 receptor inhibitors in a rare case of S310F somatic ERBB2 mutation of primary signet-ring cell adenocarcinoma of vagina: A case report and review literature of S310F somatic ERBB2 mutation in breast and gynecologic cancers
Saved in:
Main Authors: | June Y. Hou (Author), Jason D. Wright (Author), Vuthinun Achariyapota (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2020-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Development of ErbB2-Targeting Liposomes for Enhancing Drug Delivery to ErbB2-Positive Breast Cancer
by: Sho Ueno, et al.
Published: (2020) -
HER2 (ERBB2) alterations in colorectal cancers
by: Nika Tavberidze, et al.
Published: (2022) -
Role of C-erbB2 expression in gallbladder cancer
by: Niraj Kumari, et al.
Published: (2012) -
Molecular Landscape of ERBB2 Alterations in 14,956 Solid Tumors
by: Hao Wang, et al.
Published: (2022) -
cERBB-2/Her-2 Neu Overexpression and Prognostic Significance in Uterine Carcinosarcoma
by: Huseyin Salih SEMIZ, et al.
Published: (2023)